Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
Sponsor: Prokidney
Summary
The purpose of this study is to evaluate the long-term safety, efficacy, and durability in participants with chronic kidney disease (CKD) who received up to four REACT injections, delivered percutaneously into either the same or bilateral kidneys in previous studies.
Official title: A Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy From Studies REGEN-006, REGEN-007, and REGEN-015 (REGEN-008S2)
Key Details
Gender
All
Age Range
30 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-11-23
Completion Date
2030-08-31
Last Updated
2025-01-24
Healthy Volunteers
No
Interventions
Renal Autologous Cell Therapy (REACT)
No interventions in this trial
Locations (1)
Boise Kidney & Hypertension Institute
Meridian, Idaho, United States